These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10728677)

  • 21. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
    Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
    J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of apoptosis in Mv1Lu cells by expression of competitive RB1 mutants.
    Whitaker LL; Hansen MF
    Oncogene; 1997 Aug; 15(9):1069-77. PubMed ID: 9285561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a CpG island in the human LRP-2 gene and analysis of its methylation status in parathyroid adenomas.
    Knutson A; Lillhager P; Westin G
    Biol Chem; 2000; 381(5-6):433-8. PubMed ID: 10937874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    J Pathol; 2014 Aug; 233(4):392-401. PubMed ID: 24838394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
    Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
    Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
    Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
    Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
    Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
    Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus.
    Zhu J; Leon SP; Beggs AH; Busque L; Gilliland DG; Black PM
    J Clin Endocrinol Metab; 1994 Apr; 78(4):922-7. PubMed ID: 8157722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
    Esteller M; Sparks A; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Gonzalez S; Tarafa G; Sidransky D; Meltzer SJ; Baylin SB; Herman JG
    Cancer Res; 2000 Aug; 60(16):4366-71. PubMed ID: 10969779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation status of RB1 promoter in Indian retinoblastoma patients.
    Joseph B; Mamatha G; Raman G; Shanmugam MP; Kumaramanickavel G
    Cancer Biol Ther; 2004 Feb; 3(2):184-7. PubMed ID: 14726655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.